Food and Drug Administration

How quality measures can decrease cesareansCan adopting quality measures decrease the cesarean rate? Plus: The Government Accountability Office issues a report on power morcellators and the FDA's system of evaluation. Also, does the volume of one type of heart fat indicate the risk of heart disease?
USPSTF reaffirms benefit of folic acid supplementationThe USPSTF updates their 2009 statement on folic acid supplementation in women of childbearing age. Plus: The FDA releases the final advice on fish consumption.
FDA approves etanercept for pediatric psoriasisThe US Food and Drug Administration (FDA) approval of etanercept for treatment of children with moderate to severe plaque psoriasis will revolutionize the management of psoriasis in children.
Beware of nutritional supplements for kidsSales of nutritional supplements continue to rise, and available data indicate that use of these products is fairly common within the pediatric population.
AAP recommends against codeine useThe American Academy of Pediatrics (AAP) is no longer recommending codeine use in children because it can be either ineffective or too effective—leading to respiratory depression and even death.
Data lacking on labeling of opioids for kidsThe US Food and Drug Administration (FDA) recently furthered the discussion of the mind-numbing, myriad issues around the use of opioids in children.
FDA revamps nutrition facts label boxIn May 2016, the US Food and Drug Administration (FDA) announced the revamping of the rules for the “nutrition facts” label box on packaged foods, the first major such overall in 20 years.
Are breast density letters too dense?A new study looks at whether breast density letters are too difficult for the typical woman to understand. Plus: The FDA issues a warning on fluconazole and miscarriage. Also, do irregular menses provide protection against ovarian cancer or increase risk?
Pediatric drug voucher program moves through CongressThe US Food and Drug Administration (FDA) practically pleaded with Congress not to renew a 4-year-old program to give special voucher incentives to companies that develop drugs for rare pediatric diseases, saying it skews the agency’s work away from other priorities.
FDA approves morcellation containment systemThe FDA approves the first containment system for morcellation. Plus: ASRM provides guidance for Zika virus. And, the impact of HRT timing and its impact on cardiovascular disease.